Best Practice of Stability-Indicating HPLC Method Development

Tuesday, March 2, 2010

Room 207B

Tuesday’s morning session, “Best Practice of Stability-Indicating HPLC Method Development,” was arranged by LCGC contributor Michael W. Dong of Genentech. Dong will begin the session with his opening remarks on the topic promptly at 8:00 a.m.

Following Dong’s remarks will be a presentation from LCGC’s “LC Troubleshooting” Columnist John W. Dolan, of LC Resources. Dolan’s talk, “Strategies for Developing Robust HPLC Methods,” will surely be of interest to those familiar with his column and informative overall.

Next up is a presentation from Michael Dong along with his colleagues Derrick Yazzie and Nikhil Desai. Their presentation, aptly titled, “A Roadmap and Some New Tools for Rapid HPLC Method Development,” will offer new insights into HPLC method development.

“A Quality-by-Design Approach to Rapid LC Method Development,” will be presented by Richard Verseput, of S-Matrix, along with Graham Shelver. Following their talk, will be Patrick Jansen and Steven Baertschi from Eli Lilly and Company with, “Forced Degradation Studies Supporting Method Development: Best Practice and Limitations.”

Last up on the agenda is a presentation given by Merck & Co, Inc., employees Naijun Wu, Zhong Li, Robert Pascoe, Guangyu Ma, Monica Yang, and Pamela Rizos. Wu will be representing the team during the talk entitled, “Use of Ultra-high Pressure LC for Expediting Method Development and Difficult Separations.” All of the presentations in this session promise to be helpful for those working in the HPLC market.